π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-07-31
Trial ID
NCT05987696
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167164
Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Start Date
2021-03-01
Trial ID
NCT04505501
Treatments Being Tested
This is a pilot therapeutic study of related donor HLA-haploidentical NK-ce...
Status
Completed
Location
University of Minnesota
Start Date
2019-05-01
Trial ID
NCT03899480
Treatments Being Tested
SARS-CoV-2 infection mainly leads to interstitial pneumonia. The patients w...
Status
Unknown
Location
Chongqing Public Health Medical Center
Start Date
2020-02-21
Trial ID
NCT04324996
Treatments Being Tested
This clinical trial is a Single-Center, Open, Phase I/IIa Clinical Trial co...
Status
Unknown
Location
Asan Medical Center
Start Date
2021-07-08
Trial ID
NCT04872634
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167177
Phase 2, single-arm study to evaluate combination therapy of avelumab, haNK...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-02-19
Trial ID
NCT03853317
This is a single-center, open-label, Phase I/II clinical study designed to ...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2026-01-05
Trial ID
NCT07435701
Treatments Being Tested
Phase II study to determine the effects of aNK infusions in combination wit...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center
Start Date
2015-09-24
Trial ID
NCT02465957
Treatments Being Tested